Alleviation of insulin resistance and liver damage by oral administration of Imm124-E is mediated by increased Tregs and associated with increased serum GLP-1 and adiponectin: results of a phase I/II clinical trial in NASH (Q36500315)
Jump to navigation
Jump to search
scientific article published on 20 December 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Alleviation of insulin resistance and liver damage by oral administration of Imm124-E is mediated by increased Tregs and associated with increased serum GLP-1 and adiponectin: results of a phase I/II clinical trial in NASH |
scientific article published on 20 December 2012 |
Statements
1 reference
Alleviation of insulin resistance and liver damage by oral administration of Imm124-E is mediated by increased Tregs and associated with increased serum GLP-1 and adiponectin: results of a phase I/II clinical trial in NASH (English)
1 reference
Meir Mizrahi
1 reference
Yehudit Shabat
1 reference
Ami Ben Ya'acov
1 reference
Gadi Lalazar
1 reference
Tomer Adar
1 reference
Victor Wong
1 reference
Brian Muller
1 reference
Grant Rawlin
1 reference
Yaron Ilan
1 reference
1 reference
1 December 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference